On Tuesday, Shares of AT&T, Inc. (NYSE:T), gained 0.03% to $34.36.
AT&T, IBM and Mueller Water Products have developed a new solution to assist cities save water. The solution uses Internet of Things (IoT) technology that can be installed quickly to assist cities manage water and prevent leaks.
The companies are sharing results from recent trials at the National Institute of Standards and Technology (NIST) Tech Expo recently. The trials took place in Atlanta, Los Angeles and Las Vegas.
Communities everywhere are struggling to save water. Drought, old pipelines, and limited funds for new equipment all play a part. Monitoring the water system can prevent large-scale leaks. Cities can get information on the condition of their fire hydrants, underground pipes, and drainage systems which have been difficult to monitor in the past.
The solution uses Echologics sensors and sound technology from Mueller Water Products with AT&T’s LTE wireless network to detect water pressure, temperature and leaks. The IBM Water Administration Center brings all sources of water data together. It gives a complete view of past, present and future performance.
AT&T Inc. provides telecommunications services in the United States and internationally. The company operates through two segments, Wireless and Wireline. The Wireless segment offers data and voice services, counting local, long-distance, and network access services, in addition to roaming services to youth, family, professionals, small businesses, government, and business customers.
Shares of E*TRADE Financial Corporation (NASDAQ:ETFC), inclined 3.54% to $30.53, during its last trading session, hitting its highest level.
E*TRADE Financial Corporation, declared that Chief Financial Officer Matthew J. Audette advised the Company of his decision to leave to accept a role with another company. After 16 years of service, Mr. Audette will leave the Company at the end of July. Current Chief Risk Officer and E*TRADE veteran Michael A. Pizzi will assume the Chief Financial Officer role, effective June 16. Paul W. Brandow, former Chief Risk Officer and current Senior Advisor to the Company, will assume the role of Acting Chief Risk Officer to assure a smooth transition as the Company conducts a search for a permanent replacement.
Mr. Pizzi has served as Executive Vice President and CRO since January 2014, having been with E*TRADE since 2003. As CRO, Mr. Pizzi took the risk function to new levels, establishing an enterprise risk administration framework that rivals those of much larger institutions and permeates every facet of the organization from leadership down to the individual. He also has an extensive background in treasury and balance sheet administration, having served as Treasurer of E*TRADE Bank from 2008 to 2013, where he was responsible for all portfolio, capital, and liquidity administration. He took on additional responsibilities as Corporate Treasurer in 2011. Preceding to these roles, he held various positions in E*TRADE’s portfolio administration and derivatives functions. Before joining E*TRADE, Mr. Pizzi worked in asset / liability administration at both Lehman Brothers and First Maryland Bank, in addition to in capital markets research for the Federal Reserve Board.
E*TRADE Financial Corporation, a financial services company, provides brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name. It operates through two segments, Trading and Investing, and Balance Sheet Administration.
At the end of Tuesday’s trade, Shares of Qunar Cayman Islands Limited (NASDAQ:QUNR), gained 0.02% to $46.02.
Qunar Cayman Islands Limited, declared the commencement of a registered public offering of its American Depositary Shares, each representing three Class B ordinary shares, par value US$0.001 per share, by the Company.
The Company is offering an aggregate of 8,000,000 ADSs, representing 24,000,000 Ordinary Shares, subject to market conditions. The Company intends to grant to the underwriters a 30-day option to purchase up to an aggregate of 1,200,000 additional ADSs. The Company intends to use a majority of the net proceeds for general corporate purposes, counting the acquisition of new users. The Company also may use a portion of the net proceeds to acquire complementary businesses, products, services or technologies. However, the Company has not yet reached any agreements or commitments for any specific acquisitions at this time.
Goldman Sachs (Asia) L.L.C. is acting as book-running manager for the offering and BofA Merrill Lynch is acting as co-manager.
Qunar Cayman Islands Limited operates an online travel commerce platform in the People’s Republic of China. The company through its platform provides a range of travel products comprising flight tickets, hotels, vacation packages, and attraction tickets, in addition to display advertising, train tickets, car services, smart lodging, and other services.
Finally, Sigma-Aldrich Corporation (NASDAQ:SIAL), ended its last trade with -0.64% loss, and closed at $138.26.
Sigma-Aldrich Corporation, declared it has reached a contract with XCell Science to launch genetically engineered human neural differentiated cells and accompanying culture media developed to advance the research of neurological diseases. These new products, in combination with Sigma-Aldrich’s existing product portfolio, provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), in addition to for drug screening and toxicology applications in the neural space.
The range of isogenic iPSC (induced pluripotent stem cells)-derived neural cells comprise APOE knockout neurons and astrocytes, MAP2 and GFAP reporter lines, and a panel for assessment of neurotoxicity and neural protective drug candidates. All cell lines have been validated by genotyping, gene expression, karyotyping, and pluripotency, and have been further confirmed for their ability to differentiate into neural cells.
Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.